| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(80)90212-X |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000291498090212X?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:000291498090212X?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 6101296 |
| P2093 | author name string | C. M. Oakley | |
| J. F. Goodwin | |||
| W. J. McKenna | |||
| S. Chetty | |||
| P2860 | cites work | Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy | Q33151976 |
| Prognosis and mortality of hypertrophic obstructive cardiomyopathy | Q33170393 | ||
| Long-term medical management of hypertrophic obstructive cardiomyopathy | Q33171846 | ||
| Sudden Death in Cardiomyopathy | Q35809801 | ||
| Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis | Q36919424 | ||
| Asymmetrical hypertrophy of the heart in young adults | Q39319375 | ||
| Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy | Q39405155 | ||
| De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart | Q39733960 | ||
| Septal perforator compression (Narrowing) in idiopathic hypertrophic subaortic stenosis | Q39827171 | ||
| Comparison of Ventricular Ectopic Activity during 24-Hour Monitoring and Exercise Testing in Patients with Coronary Heart Disease | Q43778922 | ||
| Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation | Q51280493 | ||
| Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis | Q67015248 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P304 | page(s) | 1-5 | |
| P577 | publication date | 1980-01-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy | |
| Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy | |||
| P478 | volume | 45 |
| Q73218094 | A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment |
| Q41342502 | A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants |
| Q33174748 | Acute hemodynamic deterioration during rapid atrial pacing in patients with hypertrophic cardiomyopathy |
| Q70654162 | Arrhythmia in hypertrophic cardiomyopathy |
| Q36782521 | Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis |
| Q36782571 | Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment |
| Q70781805 | Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease |
| Q40117894 | Arrhythmias in Dilated and Hypertrophic Cardiomyopathy |
| Q40084711 | Beta-adrenergic antagonists in the treatment of patients with heart disease |
| Q36741453 | Cardiac arrhythmias in hypertrophic cardiomyopathy |
| Q39614106 | Cardiomyopathies and their role in sudden death |
| Q40092703 | Clinical applications of slow channel blocking compounds |
| Q40404084 | Current approaches in patients with ventricular tachyarrhythmias |
| Q36531820 | Evidence for or against efficacy of beta-blockers and aspirin for management of feline cardiomyopathies |
| Q36740396 | Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy |
| Q70246914 | Hypertrophic cardiomyopathy |
| Q72519406 | Hypertrophic cardiomyopathy |
| Q72580370 | Hypertrophic cardiomyopathy: a disease of impaired adenosine-mediated autoregulation of the heart |
| Q69695473 | Hypertrophic cardiomyopathy: two-dimensional echocardiographic score versus clinical and electrocardiographic findings |
| Q33172258 | Hypertrophic cardiomyopathy—Therapy with slow channel inhibiting agents |
| Q33169695 | Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death |
| Q36090333 | Myocardial ischaemia in constrictive pericarditis--a morphometric and electron microscopical study |
| Q33940862 | Nonsustained ventricular tachycardia |
| Q34172186 | Nonsustained ventricular tachycardia. A guide to the clinical significance and management |
| Q36774311 | Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study |
| Q51734985 | Pulmonary oedema in two parturients with hypertrophic obstructive cardiomyopathy (HOCM). |
| Q48545553 | Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study |
| Q72768740 | Significance of abnormal electrocardiograms in highly trained athletes |
| Q33175941 | Sudden death in hypertrophic myocardiopathy |
| Q40086997 | The frontiers of cardiomyopathy |
| Q36844192 | The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery |
| Q69549007 | Treadmill exercise test in children with cardiomyopathy and postmyocarditic myocardial hypertrophy |
| Q68136729 | Ventricular arrhythmias |
| Q42344482 | Ventricular premature beats--story petrels? |
| Q71228618 | Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room. Analysis of 17 patients |
Search more.